🇺🇸 FDA
Patent

US 12252522

Myokines for treating cell proliferative and metabolic diseases and disorders

granted A61KA61K31/282A61K38/00

Quick answer

US patent 12252522 (Myokines for treating cell proliferative and metabolic diseases and disorders) held by Northwestern University expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/282, A61K38/00, A61K38/18, A61K38/19